PRESS RELEASES

WaveImplant produces the first industrializable version of its ultrasound transducer necessary to carry out preliminary clinical trials

WaveImplant has just been able to design and produce the first industrializable model of its single-use ultrasound transducer (i.e. probe), which is part of the development of its ImplantUS medical device.

11/05/2021

WaveImplant obtains the « GOLD Company » label from EIT Health Investor Network

WaveImplant receives a new recognition from the European community of venture capital investors who, within the framework of EIT Health Investor Network awarded it the “GOLD Company” label

04/05/2021

WaveImplant winner of the Tech Tour France 2021

WaveImplant was elected among the 3 best French start-ups in the MedTech sector by an international jury of investors gathered as part of the Tech Tour France 2021 organized digitally on April 20 and 21, 2021

30/04/2021

Happy Capital assists WaveImplant in its crowdfunding operation

WaveImplant collaborates with HAPPY CAPITAL to conduct a crowdfunding operation aiming at developing ImplantUS, its medical device designed to measure dental implant stability and secure the related surgical procedures

23/03/2021

WaveImplant reinforces its management team

WaveImplant recently secured the services of Thierry Toubiana, Senior Executive and professional renowed in the dental implantology field, joining the team as Vice President Business Development & Marketing.

20/01/2021

WaveImplant announces the closing of a first pre-seed round of 170k€

Thanks to different investors belonging to the industrial network of its founders, WaveImplant succeeded in a first significant capital increase.

09/12/2020